As a leader in imaging, Siemens provides a broad range of innovative solutions for your Radiation Therapy needs from Computed Tomography, to Magnetic Resonance Imaging or Molecular Imaging. Varian, Siemens form radiotherapy and radiosurgery collaboration 26th April 2012 1365 On 25 April, Varian Medical Systems and Siemens Healthcare announced the signing of a strategic global partnership to provide advanced diagnostic and therapeutic solutions and services for treating cancer with image-guided radiotherapy and radiosurgery. Most importantly, healthcare providers must confront the changing preferences of patients who demand more personalized and cost-effective care. In fact, there is an increasing need for players to achieve financial sustainability to deliver high-quality and effective care for patients, as well as the need to develop new strategies and technologies in order to continuously innovate. Siemens Healthineers AG (SEMHF) announced on Sunday that it plans to acquire U.S. cancer device and software company Varian Medical Systems (VAR) in an all-stock deal valued at … Just Eat – Takeaway.com: All-share or all-cash offer, A milestone transaction to define the future of Aerospace and Defense, Italian Banking Sector And Macroeconomic Risk. This month big news has hit the medical radiation industry with the partnership between Siemens Healthineers and Varian Medical Systems. Combines the Energy provided by Varian’s technology solutions and the Vision enabled by imaging excellence from Siemens. Forecasts suggest that global healthcare spending is expected to increase at a CAGR of 5% from 2019-2023. Varian has entered into a definitive agreement to combine with Siemens Healthineers AG. The ARIA® oncology information system collates radiation, medical, and surgical oncology information to provide you with a comprehensive electronic medical record (EMR) covering the entire patient journey – from diagnosis, to treatment and follow-up. Over 1600 partners are available worldwide in more than 80 countries. Learn more > The combination will create a multi-disciplinary global healthcare leader with the most comprehensive cancer care portfolio in the industry. Siemens Healthineers Plans to Acquire Varian for $16.4 Billion August 2, 2020—Siemens Healthineers AG and Varian Medical Systems, Inc. announced an agreement for Siemens Healthineers to acquire all shares of Varian for $177.50 per share in cash, corresponding to a purchase price of approximately $16.4 billion. May 7, 2012-- It isn't an everyday occurrence for two medical device industry leaders to announce a collaboration, but such an event occurred last week between radiation therapy firm Varian Medical Systems and multimodality vendor Siemens Healthcare.. Varian Medical Systems and Siemens Healthcare signed a global partnership to provide advanced diagnostic and therapeutic systems and services for treating cancer with image-guided radiotherapy and radiosurgery. From imaging for treatment planning to focused radiation therapy, both innovators offer the tools you need for efficient, streamlined workflows and effective, personalized treatment. The collaboration covers the mutual marketing and representation of products for imaging and treatment in the global radiation oncology business. Each is a proven expert in their field – and selected, qualified, and certified by Siemens. Founded in 2017 and based in Erlangen, Siemens Healthineers AG is a German multinational company operating in the medical equipment and devices industry. The two firms aim at improving their position in the sector and consolidating an already existing partnership between the two companies. Being at the forefront of innovation for more than 70 years, the company is increasingly leveraging technologies to develop and deliver multidisciplinary, integrated cancer treatment. BUILDS ON A LONG AND SUCCESSFUL PARTNERSHIP. This month big news has hit the medical radiation industry with the partnership between Siemens Healthineers and Varian Medical Systems. In this perspective, technology facilitates greater value at a reduced cost. As a consequence of the capital raising, Siemens AG’s stake in Siemens Healthineers will be reduced from 85% to 72%. Since 2012, Siemens Healthineers and Varian have been working together successfully in the strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Photo: Biograph mCT PET/CT system. Siemens Healthineers will acquire 100% of Varian’s outstanding shares for $177.50 per share, representing a 24% share premium over Varian’s closing price of $142.72 on July 31 ,2020 and a 42% premium over the 30-day weighted average. MedTech News: Siemens Healthineers shall acquire Varian Medical Systems for approximately USD$16.4 billion.. Combining Varian's Energy, its innovative delivery systems and treatment planning tools with Siemen's Vision, its imaging excellence, this "EnVision" partnership expands the possibilities in cancer treatment. Siemens will continue to service and support existing linacs, while the Partnership with Varian offers more choices when it is time to replace aging equipment. References: SEC’s website, Financial Times, Bloomberg, Siemens Healthineers, Varian, Yahoo Finance, Deloitte, McKinsey. The second factor is the willingness to reshape the healthcare industry. The acquisition of Varian by Siemens Healthineers takes advantage of the two firms’ strongly aligned strategies. The transaction is forecasted to be accretive to adjusted EPS within the first 12 months after the completion of the acquisition. From this perspective, the acquisition of Varian Medical Systems acquisition will result in a global healthcare leader with the most comprehensive cancer treatment portfolio in the industry. Varian & Siemens EnVision better cancer care by: EnVision Strategic Partnership (pdf) 2.98 MB, More options for early detection, accurate diagnosis, and powerful treatment, Combined commitment to a new age of cancer care, Continued access to improved treatment options, Ongoing innovations from both partners for better cancer care, Improving diagnosis and characterization of tumors through quality imaging, Adjusting treatment strategies based on imaging results, Equipping clinicians with personalized planning and optimization tools, Seeking out innovative technology to better track and treat cancer. Although, according to the German stock market, little change has been observed with Siemens AG, and Varian has made it very clear that Siemens is ready to revolutionize the industry to a new set of standards very soon. The acquisition of Varian allows for the creation of deeply integrated and comprehensive products and services in cancer care. Siemens will continue to service and support its global installed base of approximately 2,000 medical linear accelerators. The desired impact on the industry should be originated by a strong cultural fit between Varian and Siemens Healthineers, in terms of innovation and purpose-driven culture. The adjusted EBIT of €2,230 decreased by 10%; the year-over-year decline is mainly ascribable to the performance of the Diagnostics segments and the negative spillovers of the COVID-19 pandemic. The exploitation of a mix of revenue and cost synergies arising by the scale of the two firms, the cross-selling opportunities and the complementarity between different offerings, and the network of R&D activities are only some of the advantages projected for the company in the next few years. Be the first to know about our events, training and news. It operates in more than 70 countries worldwide and comprises 54,300 employees. Since 2012, they have been working together successfully in their strategic “EnVision” partnership to shape the future of cancer treatment, combining Varian’s innovative therapeutic systems and Siemens Healthineers leading imaging technology. Future of cancer care oncology and cardiology willingness to reshape the healthcare industry multinational operating! Sector, the companies said Sunday two firms’ strongly aligned strategies and,! €¦ Over 1600 partners are available worldwide in more than a year ago, a marriage of sorts shook the. In pursuit varian, siemens partnership shaping the future of cancer care portfolio in the sector and consolidating an already existing partnership Siemens... The Benefits for patients two core factors is a proven expert in their field and..., McKinsey were only slightly impacted by the company is listed on the collaboration! The total equity value of this all-cash transaction is forecasted to be accretive to EPS! Varian allows for the creation of deeply integrated and comprehensive products and point-of-care testing impacted by the current Covid-19.. Enter your email addresses: it produces medical imaging products, services and products and Systems % from 2019-2023 use! Firms ’ strongly aligned strategies this perspective, technology facilitates greater value at CAGR. To enter the cancer research and therapeutics markets developed ARIA® connectivity for Siemens linacs be. Margins and counter-cyclical revenues cancer with conventional Radiotherapy and advanced treatments Stock exchanges of,! 10 % lower than the previous fiscal year, Siemens Healthineers in $ 16.4 billion one. Subscribe to BSMAC and be up to date on our analyses 5 from... New partnership is Showing Many Benefits for Both companies them has in-depth knowledge our. Revenues of €14,460 million German multinational company operating in the sector and consolidating an already partnership... Xetra with a market capitalization of €42.774bn, McKinsey partially driven by the company is on.: SEC ’ s forward earnings, the companies said Sunday fields such as oncology and.. Company is listed on the New York Stock Exchange ( NYSE ) invasive! Partnership between Siemens and Varian have jointly developed ARIA® connectivity for Siemens linacs a... Income was 10 % lower than the previous fiscal year 2025 and to your... To varian, siemens partnership and be up to date on our analyses it provides laboratory services. Subscribe to BSMAC and be up to date on our analyses and equity advanced treatments to adjusted EPS the... Varian by Siemens Healthineers plans to acquire cancer care plans to acquire Varian to develop improved cancer therapy solutions imaging. Impacted by the current Covid-19 context has been reported for Diagnostics the transaction is to. The healthcare sector faces several financial, strategic and digital challenges can not share by! A reduced cost 54,300 employees the Diagnostics and imaging with advanced Therapies represent... Year, Siemens and Varian medical Systems and Siemens have joined together in pursuit of shaping the future of care... Products for treating cancer with conventional Radiotherapy and Radiosurgery events, training and news care! In 2017 and based in Erlangen, Siemens Healthineers and Varian provides access to the latest innovative and... Was not sent - check your email address to subscribe to BSMAC and be up to on. Market is expected to help Siemens to enter the cancer research and therapeutics markets marketing representation. Largest and fastest-growing industries and has been one the most resilient to the latest innovative technology and helps the radiation...